Autocrine activity of soluble Flt-1 controls endothelial cell function and angiogenesis

Shakil Ahmad, Peter W. Hewett, Bahjat Al-Ani, Samir Sissaoui, Takeshi Fujisawa, Melissa J. Cudmore, Asif Ahmed

Research output: Contribution to journalArticle

Abstract

Background - The negative feedback system is an important physiological regulatory mechanism controlling angiogenesis. Soluble vascular endothelial growth factor (VEGF) receptor-1 (sFlt-1), acts as a potent endogenous soluble inhibitor of VEGF- and placenta growth factor (PlGF)-mediated biological function and can also form dominant-negative complexes with competent full-length VEGF receptors.

Methods and results - Systemic overexpression of VEGF-A in mice resulted in significantly elevated circulating sFlt-1. In addition, stimulation of human umbilical vein endothelial cells (HUVEC) with VEGF-A, induced a five-fold increase in sFlt-1 mRNA, a time-dependent significant increase in the release of sFlt-1 into the culture medium and activation of the flt-1 gene promoter. This response was dependent on VEGF receptor-2 (VEGFR-2) and phosphoinositide-3'-kinase signalling. siRNA-mediated knockdown of sFlt-1 in HUVEC stimulated the activation of endothelial nitric oxide synthase, increased basal and VEGF-induced cell migration and enhanced endothelial tube formation on growth factor reduced Matrigel. In contrast, adenoviral overexpression of sFlt-1 suppressed phosphorylation of VEGFR-2 at tyrosine 951 and ERK-1/-2 MAPK and reduced HUVEC proliferation. Preeclampsia is associated with elevated placental and systemic sFlt-1. Phosphorylation of VEGFR-2 tyrosine 951 was greatly reduced in placenta from preeclamptic patients compared to gestationally-matched normal placenta.

Conclusion - These results show that endothelial sFlt-1 expression is regulated by VEGF and acts as an autocrine regulator of endothelial cell function.
LanguageEnglish
Article number15
JournalVascular Cell
Volume3
Issue number1
DOIs
Publication statusPublished - 13 Jul 2011

Fingerprint

Endothelial cells
Vascular Endothelial Growth Factor A
Endothelial Cells
Vascular Endothelial Growth Factor Receptor
Human Umbilical Vein Endothelial Cells
Placenta
Phosphorylation
Vascular Endothelial Growth Factor Receptor-1
Vascular Endothelial Growth Factor Receptor-2
1-Phosphatidylinositol 4-Kinase
Nitric Oxide Synthase Type III
Pre-Eclampsia
Small Interfering RNA
Cell Movement
Culture Media
Intercellular Signaling Peptides and Proteins
Chemical activation
Cell Proliferation
Messenger RNA
Nitric oxide

Bibliographical note

© 2011 Ahmad et al; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Cite this

Ahmad, Shakil ; Hewett, Peter W. ; Al-Ani, Bahjat ; Sissaoui, Samir ; Fujisawa, Takeshi ; Cudmore, Melissa J. ; Ahmed, Asif. / Autocrine activity of soluble Flt-1 controls endothelial cell function and angiogenesis. In: Vascular Cell. 2011 ; Vol. 3, No. 1.
@article{85cb9ef9f04a463da72c6452258e3a86,
title = "Autocrine activity of soluble Flt-1 controls endothelial cell function and angiogenesis",
abstract = "Background - The negative feedback system is an important physiological regulatory mechanism controlling angiogenesis. Soluble vascular endothelial growth factor (VEGF) receptor-1 (sFlt-1), acts as a potent endogenous soluble inhibitor of VEGF- and placenta growth factor (PlGF)-mediated biological function and can also form dominant-negative complexes with competent full-length VEGF receptors. Methods and results - Systemic overexpression of VEGF-A in mice resulted in significantly elevated circulating sFlt-1. In addition, stimulation of human umbilical vein endothelial cells (HUVEC) with VEGF-A, induced a five-fold increase in sFlt-1 mRNA, a time-dependent significant increase in the release of sFlt-1 into the culture medium and activation of the flt-1 gene promoter. This response was dependent on VEGF receptor-2 (VEGFR-2) and phosphoinositide-3'-kinase signalling. siRNA-mediated knockdown of sFlt-1 in HUVEC stimulated the activation of endothelial nitric oxide synthase, increased basal and VEGF-induced cell migration and enhanced endothelial tube formation on growth factor reduced Matrigel. In contrast, adenoviral overexpression of sFlt-1 suppressed phosphorylation of VEGFR-2 at tyrosine 951 and ERK-1/-2 MAPK and reduced HUVEC proliferation. Preeclampsia is associated with elevated placental and systemic sFlt-1. Phosphorylation of VEGFR-2 tyrosine 951 was greatly reduced in placenta from preeclamptic patients compared to gestationally-matched normal placenta. Conclusion - These results show that endothelial sFlt-1 expression is regulated by VEGF and acts as an autocrine regulator of endothelial cell function.",
author = "Shakil Ahmad and Hewett, {Peter W.} and Bahjat Al-Ani and Samir Sissaoui and Takeshi Fujisawa and Cudmore, {Melissa J.} and Asif Ahmed",
note = "{\circledC} 2011 Ahmad et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",
year = "2011",
month = "7",
day = "13",
doi = "10.1186/2045-824X-3-15",
language = "English",
volume = "3",
journal = "Vascular Cell",
issn = "2045-824X",
publisher = "BioMed Central",
number = "1",

}

Autocrine activity of soluble Flt-1 controls endothelial cell function and angiogenesis. / Ahmad, Shakil; Hewett, Peter W.; Al-Ani, Bahjat; Sissaoui, Samir; Fujisawa, Takeshi; Cudmore, Melissa J.; Ahmed, Asif.

In: Vascular Cell, Vol. 3, No. 1, 15, 13.07.2011.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Autocrine activity of soluble Flt-1 controls endothelial cell function and angiogenesis

AU - Ahmad, Shakil

AU - Hewett, Peter W.

AU - Al-Ani, Bahjat

AU - Sissaoui, Samir

AU - Fujisawa, Takeshi

AU - Cudmore, Melissa J.

AU - Ahmed, Asif

N1 - © 2011 Ahmad et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PY - 2011/7/13

Y1 - 2011/7/13

N2 - Background - The negative feedback system is an important physiological regulatory mechanism controlling angiogenesis. Soluble vascular endothelial growth factor (VEGF) receptor-1 (sFlt-1), acts as a potent endogenous soluble inhibitor of VEGF- and placenta growth factor (PlGF)-mediated biological function and can also form dominant-negative complexes with competent full-length VEGF receptors. Methods and results - Systemic overexpression of VEGF-A in mice resulted in significantly elevated circulating sFlt-1. In addition, stimulation of human umbilical vein endothelial cells (HUVEC) with VEGF-A, induced a five-fold increase in sFlt-1 mRNA, a time-dependent significant increase in the release of sFlt-1 into the culture medium and activation of the flt-1 gene promoter. This response was dependent on VEGF receptor-2 (VEGFR-2) and phosphoinositide-3'-kinase signalling. siRNA-mediated knockdown of sFlt-1 in HUVEC stimulated the activation of endothelial nitric oxide synthase, increased basal and VEGF-induced cell migration and enhanced endothelial tube formation on growth factor reduced Matrigel. In contrast, adenoviral overexpression of sFlt-1 suppressed phosphorylation of VEGFR-2 at tyrosine 951 and ERK-1/-2 MAPK and reduced HUVEC proliferation. Preeclampsia is associated with elevated placental and systemic sFlt-1. Phosphorylation of VEGFR-2 tyrosine 951 was greatly reduced in placenta from preeclamptic patients compared to gestationally-matched normal placenta. Conclusion - These results show that endothelial sFlt-1 expression is regulated by VEGF and acts as an autocrine regulator of endothelial cell function.

AB - Background - The negative feedback system is an important physiological regulatory mechanism controlling angiogenesis. Soluble vascular endothelial growth factor (VEGF) receptor-1 (sFlt-1), acts as a potent endogenous soluble inhibitor of VEGF- and placenta growth factor (PlGF)-mediated biological function and can also form dominant-negative complexes with competent full-length VEGF receptors. Methods and results - Systemic overexpression of VEGF-A in mice resulted in significantly elevated circulating sFlt-1. In addition, stimulation of human umbilical vein endothelial cells (HUVEC) with VEGF-A, induced a five-fold increase in sFlt-1 mRNA, a time-dependent significant increase in the release of sFlt-1 into the culture medium and activation of the flt-1 gene promoter. This response was dependent on VEGF receptor-2 (VEGFR-2) and phosphoinositide-3'-kinase signalling. siRNA-mediated knockdown of sFlt-1 in HUVEC stimulated the activation of endothelial nitric oxide synthase, increased basal and VEGF-induced cell migration and enhanced endothelial tube formation on growth factor reduced Matrigel. In contrast, adenoviral overexpression of sFlt-1 suppressed phosphorylation of VEGFR-2 at tyrosine 951 and ERK-1/-2 MAPK and reduced HUVEC proliferation. Preeclampsia is associated with elevated placental and systemic sFlt-1. Phosphorylation of VEGFR-2 tyrosine 951 was greatly reduced in placenta from preeclamptic patients compared to gestationally-matched normal placenta. Conclusion - These results show that endothelial sFlt-1 expression is regulated by VEGF and acts as an autocrine regulator of endothelial cell function.

UR - http://www.scopus.com/inward/record.url?scp=81855186308&partnerID=8YFLogxK

U2 - 10.1186/2045-824X-3-15

DO - 10.1186/2045-824X-3-15

M3 - Article

VL - 3

JO - Vascular Cell

T2 - Vascular Cell

JF - Vascular Cell

SN - 2045-824X

IS - 1

M1 - 15

ER -